New AI tools offer hope for global TB elimination
Researchers have unveiled new AI tools, from smartphone cough analysis to child-friendly screening systems, which could transform how…
MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
MannKind MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation…
Blood biomarkers offer hope for early detection of interstitial lung disease
UVA Health lung researchers are developing a promising approach to detecting patients at risk of interstitial lung disease…
Inhaling marijuana associated with increased odds of developing asthma
If you’re looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then…
Extended apixaban therapy lowers recurrent VTE in patients with provoked events and enduring risk factors
Apixaban 2.5 mg twice daily significantly reduced symptomatic venous thromboembolism (VTE) recurrence, with a low risk of major…